TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07884721: A Randomized, Multicentric, Open-Label Trial to Investigate the Benefit of Adding Fasten Onco Digital Therapy Integrating a Fasting Mimicking Diet During Neoadjuvant Treatment to Standard of Care, Compared to Standard of

Sponsor: FASTEN · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 144 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$11,781,000

Rescue Site Savings

+$7,761,600

Unlock Full NCT07884721 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07884721 Rescue Dossier →